retatrutide black market Demand for Unapproved Weight-Loss Drug Surges on Social Media Swissmedic issues warning against falsified
Description
Join 500,000+ happy customers today.
Right now, GLP-1s get all the attention
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in people with diabetes.
energy usage
Almost one-third (31%) of all patients dispensed the drugs in 2023 had no recorded diagnosis of either diabetes or obesity, compared to 8% in 2019
